Tenaya Therapeutics Inc (TNYA)
4.65
-0.03
(-0.64%)
USD |
NASDAQ |
May 02, 14:49
Tenaya Therapeutics Free Cash Flow: -103.31M for Dec. 31, 2023
Free Cash Flow Chart
Historical Free Cash Flow Data
Date | Value |
---|---|
December 31, 2023 | -103.31M |
September 30, 2023 | -104.47M |
June 30, 2023 | -112.44M |
March 31, 2023 | -118.62M |
December 31, 2022 | -125.05M |
September 30, 2022 | -130.48M |
June 30, 2022 | -120.52M |
Date | Value |
---|---|
March 31, 2022 | -103.17M |
December 31, 2021 | -85.93M |
September 30, 2021 | -75.61M |
June 30, 2021 | -63.64M |
March 31, 2021 | -56.65M |
December 31, 2020 | -45.21M |
Free Cash Flow Range, Past 5 Years
-130.48M
Minimum
Sep 2022
-45.21M
Maximum
Dec 2020
-95.78M
Average
-103.31M
Median
Dec 2023
Free Cash Flow Benchmarks
Adverum Biotechnologies Inc | -91.71M |
Solid Biosciences Inc | -95.70M |
Dyne Therapeutics Inc | -188.89M |
Sana Biotechnology Inc | -273.61M |
Prime Medicine Inc | -174.14M |
Free Cash Flow Related Metrics
Cash from Operations (Quarterly) | -21.92M |
Cash from Investing (Quarterly) | -14.92M |
Cash from Financing (Quarterly) | 0.371M |
Free Cash Flow Per Share (Quarterly) | -0.2999 |
Free Cash Flow Yield | -30.14% |